Health Condition 1: O244- Gestational diabetes mellitus Health Condition 2: O241- Pre-existing type 2 diabetes mellitus, in pregnancy, childbirth and the puerperium
Conditions
Interventions
Intervention1: FLASH GLUCOSE MONITORING DEVICE (FGM is being manufactured by ABBOTT Diabetes care by the name of Freestyle Libre Pro)
: Pregnant women with diabetes on insulin will undergo continuous
Sponsors
DELHI DIABETIC FORUM
Eligibility
Inclusion criteria
Inclusion criteria: .Diagnosed cases of pregnancy with diabetes mellitus (including both GDM and overt DM) on insulin therapy. • Period of gestation 24-36 weeks of gestation. • Singleton pregnancy. • Women who can understand hindi / English and can keep a diet diary and insulin chart and are willing to follow the study protocol.
Exclusion criteria
Exclusion criteria: • Pregnancy complicated with other chronic medical illness. • Known case of Psychiatric illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of glycemic control after 2 weeks treatment based on glycemic monitoring measured by flash glucose monitoring and self- monitoring of blood glucose in pregnant women with diabetes mellitus on insulinTimepoint: 2 weeks and 1 month | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Compare Patient satisfaction based on diabetes treatment satisfaction questionnaire (DTSQ) between FGM and SMBG groups at the end of 14 days. 2. To compare serum Fructosamine level at recruitment and at the end of 2 weeks. 3. To compare sustainability of glycemic control at the end of 4 weeks in both groups by measuring mean blood glucose , SD, proportion of women having normoglycemia (70 to 140mg/dl), Fructosamine and HbA1C level. 4. Any adverse effect due to FGM will be notedTimepoint: 2 weeks and 1 month | — |
Countries
India
Contacts
Public ContactGunjan
Lady Hardinge Medical College
Outcome results
None listed